---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-060586"
form_type: "8-K"
ticker: "RANI"
cik: "0001856725"
company_name: "Rani Therapeutics Holdings, Inc."
filed_at: "2025-04-30T23:59:59+00:00"
generated_at: "2026-05-23T02:41:16.985872+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Director Laureen DeBuono retires from Rani Therapeutics board; committees reconstituted

## Summary
- Laureen DeBuono resigned from Board effective April 24, 2025; no disagreement with company.
- Board reconstituted Audit Committee: Rometty (Chair), Butel, Nanavaty; Compensation: Nanavaty (Chair), Ausiello.
- Nominating and Governance Committee: Butel (Chair), Ausiello, Rometty.

## SEC filing metadata
- accession: 0000950170-25-060586
- form_type: 8-K
- ticker: RANI
- cik: 0001856725
- company_name: Rani Therapeutics Holdings, Inc.
- filed_at: 2025-04-30T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1856725/000095017025060586/0000950170-25-060586-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1856725/000095017025060586/rani-20250424.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-060586
- JSON: https://secwatch.observer/filing/0000950170-25-060586.json
- Plain text: https://secwatch.observer/filing/0000950170-25-060586.txt

## Key facts
- Executive change
  Laureen DeBuono retired as Director at Rani Therapeutics Holdings, Inc..
  - Action: retired
  - Role: Director
  source text: On April 24, 2025, Laureen DeBuono notified the Board of Directors (“Board”) of Rani Therapeutics Holdings, Inc. (the “Company”) that she has decided to retire from the Board effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1856725/000095017025060586/0000950170-25-060586-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.